These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 28076844

  • 1. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
    Li QQ, Xie YK, Wu Y, Li LL, Liu Y, Miao XB, Liu QZ, Yao KT, Xiao GH.
    Oncotarget; 2017 Feb 14; 8(7):12067-12080. PubMed ID: 28076844
    [Abstract] [Full Text] [Related]

  • 2. LncRNA HAR1A inhibits non-small cell lung cancer growth by downregulating c-MYC transcripts and facilitating its proteasomal degradation.
    Ma J, Zhang P, Wang Y, Lu M, Cao K, Wei S, Qi C, Ling X, Zhu J.
    Int Immunopharmacol; 2024 Dec 05; 142(Pt B):113264. PubMed ID: 39340992
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
    Sun W, Ping W, Tian Y, Zou W, Liu J, Zu Y.
    Cell Physiol Biochem; 2018 Dec 05; 51(5):2160-2171. PubMed ID: 30522099
    [Abstract] [Full Text] [Related]

  • 6. Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits.
    Vyas AR, Moura MB, Hahm ER, Singh KB, Singh SV.
    J Cell Biochem; 2016 Nov 05; 117(11):2482-95. PubMed ID: 26990292
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.
    Huang G, Lou T, Pan J, Ye Z, Yin Z, Li L, Cheng W, Cao Z.
    Aging (Albany NY); 2019 Apr 12; 11(7):2138-2150. PubMed ID: 30981205
    [Abstract] [Full Text] [Related]

  • 9. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F, Pan Q, Yu H, Yue X.
    J Neurochem; 2015 Sep 12; 134(5):811-8. PubMed ID: 25991372
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents.
    Klingbeil O, Lesche R, Gelato KA, Haendler B, Lejeune P.
    Cell Death Dis; 2016 Sep 08; 7(9):e2365. PubMed ID: 27607580
    [Abstract] [Full Text] [Related]

  • 11. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS, Zheng YL, Zhao J, Chun X.
    Biomed Pharmacother; 2018 Feb 08; 98():538-544. PubMed ID: 29287202
    [Abstract] [Full Text] [Related]

  • 12. A PolH Transcript with a Short 3'UTR Enhances PolH Expression and Mediates Cisplatin Resistance.
    Zhang J, Sun W, Ren C, Kong X, Yan W, Chen X.
    Cancer Res; 2019 Jul 15; 79(14):3714-3724. PubMed ID: 31064846
    [Abstract] [Full Text] [Related]

  • 13. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X, Chen Y, Shen Y, Tantai J.
    Cell Death Dis; 2019 Jun 03; 10(6):429. PubMed ID: 31160576
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
    Cheng R, Lu C, Zhang G, Zhang G, Zhao G.
    Oncol Rep; 2017 Apr 03; 37(4):2129-2136. PubMed ID: 28350100
    [Abstract] [Full Text] [Related]

  • 15. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.
    Wang DX, Zou YJ, Zhuang XB, Chen SX, Lin Y, Li WL, Lin JJ, Lin ZQ.
    Acta Pharmacol Sin; 2017 Feb 03; 38(2):241-251. PubMed ID: 27890917
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
    Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y, Liu X.
    Cancer Genet; 2014 May 03; 207(5):214-20. PubMed ID: 24906642
    [Abstract] [Full Text] [Related]

  • 17. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L, Xu J, Zhao F, Dai X, Tao J, Pan J, Shi A, Shen Z, Su C, Zhang Y.
    Eur J Pharmacol; 2021 May 15; 899():174054. PubMed ID: 33771522
    [Abstract] [Full Text] [Related]

  • 18. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells.
    Gong TT, Liu XD, Zhan ZP, Wu QJ.
    Exp Cell Res; 2020 Aug 15; 393(2):112061. PubMed ID: 32437713
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.
    Shi L, Xu Z, Wu G, Chen X, Huang Y, Wang Y, Jiang W, Ke B.
    BMC Cancer; 2017 Feb 15; 17(1):138. PubMed ID: 28202053
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
    Yang T, Chen T, Li Y, Gao L, Zhang S, Wang T, Chen M.
    Tumour Biol; 2015 Mar 15; 36(3):1903-11. PubMed ID: 25432132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.